Rectal Adenocarcinoma with Germ-Cell Differentiation: Report of a Case

Teresa A. Coleman; Charles D. Redger; Randy L. Hamill; Paul M Dainer

doi:10.1007/BF02660779

Rectal Adenocarcinoma with Germ-Cell Differentiation: Report of a Case

Teresa A. Coleman, Charles D. Redger, Randy L. Hamill, Paul M Dainer

Research output: Contribution to journal › Article

1 Scopus citations

Abstract

A 26-year-old male presented with a colorectal adenocarcinoma with germ-cell differentiation and an isolated elevation of serum alpha-fetoprotein. He was treated with platinum/etoposide/bleomycin chemotherapy with a decrease in serum alpha-fetoprotein and in the size of the primary tumor. An ongoing tumor-marker response occurred when the patient was switched to concurrent 5-fluorouracil chemotherapy and radiation therapy. The patient underwent a palliative diversion of his rectal cancer 10 months after diagnosis, developed liver metastasis at 12 months, and died 20 months after diagnosis.

Original language	English (US)
Pages (from-to)	1702-1705
Number of pages	4
Journal	Diseases of the Colon and Rectum
Volume	46
Issue number	12
DOIs	https://doi.org/10.1007/BF02660779
State	Published - Dec 2003
Externally published	Yes

Keywords

Alpha-fetoprotein
Colorectal carcinoma
Germ-cell differentiation
Platinum/etoposide/ bleomycin chemotherapy

ASJC Scopus subject areas

Gastroenterology

Access to Document

10.1007/BF02660779

Fingerprint Dive into the research topics of 'Rectal Adenocarcinoma with Germ-Cell Differentiation: Report of a Case'. Together they form a unique fingerprint.

Cite this

Coleman, T. A., Redger, C. D., Hamill, R. L., & Dainer, P. M. (2003). Rectal Adenocarcinoma with Germ-Cell Differentiation: Report of a Case. Diseases of the Colon and Rectum, 46(12), 1702-1705. https://doi.org/10.1007/BF02660779

@article{11a04af1229d4d979719be0674f9942b,

title = "Rectal Adenocarcinoma with Germ-Cell Differentiation: Report of a Case",

abstract = "A 26-year-old male presented with a colorectal adenocarcinoma with germ-cell differentiation and an isolated elevation of serum alpha-fetoprotein. He was treated with platinum/etoposide/bleomycin chemotherapy with a decrease in serum alpha-fetoprotein and in the size of the primary tumor. An ongoing tumor-marker response occurred when the patient was switched to concurrent 5-fluorouracil chemotherapy and radiation therapy. The patient underwent a palliative diversion of his rectal cancer 10 months after diagnosis, developed liver metastasis at 12 months, and died 20 months after diagnosis.",

keywords = "Alpha-fetoprotein, Colorectal carcinoma, Germ-cell differentiation, Platinum/etoposide/ bleomycin chemotherapy",

author = "Coleman, {Teresa A.} and Redger, {Charles D.} and Hamill, {Randy L.} and Dainer, {Paul M}",

year = "2003",

month = dec,

doi = "10.1007/BF02660779",

language = "English (US)",

volume = "46",

pages = "1702--1705",

journal = "Diseases of the Colon and Rectum",

issn = "0012-3706",

publisher = "Lippincott Williams and Wilkins",

number = "12",

}

TY - JOUR

T1 - Rectal Adenocarcinoma with Germ-Cell Differentiation

T2 - Report of a Case

AU - Coleman, Teresa A.

AU - Redger, Charles D.

AU - Hamill, Randy L.

AU - Dainer, Paul M

PY - 2003/12

Y1 - 2003/12

N2 - A 26-year-old male presented with a colorectal adenocarcinoma with germ-cell differentiation and an isolated elevation of serum alpha-fetoprotein. He was treated with platinum/etoposide/bleomycin chemotherapy with a decrease in serum alpha-fetoprotein and in the size of the primary tumor. An ongoing tumor-marker response occurred when the patient was switched to concurrent 5-fluorouracil chemotherapy and radiation therapy. The patient underwent a palliative diversion of his rectal cancer 10 months after diagnosis, developed liver metastasis at 12 months, and died 20 months after diagnosis.

AB - A 26-year-old male presented with a colorectal adenocarcinoma with germ-cell differentiation and an isolated elevation of serum alpha-fetoprotein. He was treated with platinum/etoposide/bleomycin chemotherapy with a decrease in serum alpha-fetoprotein and in the size of the primary tumor. An ongoing tumor-marker response occurred when the patient was switched to concurrent 5-fluorouracil chemotherapy and radiation therapy. The patient underwent a palliative diversion of his rectal cancer 10 months after diagnosis, developed liver metastasis at 12 months, and died 20 months after diagnosis.

KW - Alpha-fetoprotein

KW - Colorectal carcinoma

KW - Germ-cell differentiation

KW - Platinum/etoposide/ bleomycin chemotherapy

UR - http://www.scopus.com/inward/record.url?scp=0346780670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346780670&partnerID=8YFLogxK

U2 - 10.1007/BF02660779

DO - 10.1007/BF02660779

M3 - Article

C2 - 14668599

AN - SCOPUS:0346780670

VL - 46

SP - 1702

EP - 1705

JO - Diseases of the Colon and Rectum

JF - Diseases of the Colon and Rectum

SN - 0012-3706

IS - 12

ER -